Merck Settles Gardasil Vaccine Injury Lawsuit for $50 Million
Merck & Co has agreed to pay $50 million to settle more than 200 lawsuits brought against the drug giant by patients suffering from autoimmune disorders after receiving the Gardasil vaccine. According Merck, this settlement resolves all but one of the pending lawsuits filed against its HPV vaccine.1 Gardasil was fast-tracked to licensure by the […]
Study Finds Ivermectin and Mebendazole Beneficial in Treating Cancer
A new peer-reviewed study on ivermectin and mebendazole as a cancer treatment has been published in the international oncology journal Anticancer Research. The study found that 84.4 percent of cancer patients taking ivermectin and mebendazole for six months reported cancer disappearance, tumor regression, or cancer stabilization.1 Described by its authors as the largest real-world human […]
Parkinson’s Disease Costs Projected to Reach $112 Billion by 2045
According to an economic burden analysis commissioned by the Michael J. Fox Foundation for Parkinson’s Research (MJFF), the total economic impact of Parkinson’s disease in the United States is projected to reach $112 billion by 2045, representing a substantial increase over current estimates. The analysis evaluated direct medical, indirect, and non-medical costs and reflects a […]
“Profound Autism” Under Consideration as New Diagnosis
Autism has emerged as one of the most intensely debated public health issues over the past three decades, but especially during the past year. U.S. Secretary of Health and Human Services Robert F. Kennedy, Jr. has vowed to launch a sweeping research initiative aimed at identifying underlying causes of autism—a move applauded by some advocates […]
CDC Will Offer Contract to Investigate Link Between Autism and Vaccination
The U.S. Centers for Disease Control and Prevention (CDC) intends to award a contract to Rensselaer Polytechnic Institute (RPI) to investigate links between autism prevalence and vaccination according to a notice on the federal website. The notice, posted in September 2025, indicated that the CDC planned to issue the fixed-price contract to the New York […]
Cancer Treatments Using mRNA Technology Targeted as COVID Shots Sales Decline
BioNTech SE and Moderna, Inc., two leading pharmaceutical companies that developed the mRNA COVID-19 biological, are facing new financial and regulatory challenges as demand for COVID booster shots continues to fall and U.S. health policy changes reshape the vaccine market.1 Moderna cut its 2025 sales forecast to between $1.5 billion and $2.2 billion, down as […]